Newbridge Financial Services Group’s Twist Bioscience TWST Stock Holding History

Newbridge Financial Services Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53	Closed	-$2K	–	1479
2022 Q2	$2K	Sell	53 -24	-31%	-$850	﹤0.01%	1227
2022 Q1	$4K	Hold	77	–	–	﹤0.01%	1161
2021 Q4	$6K	Hold	77	–	–	﹤0.01%	1044
2021 Q3	$8K	Buy	77 +25	+48%	+$2.86K	0.01%	933
2021 Q2	$7K	Hold	52	–	–	﹤0.01%	1059
2021 Q1	$6K	Sell	52 -22	-30%	-$3.34K	﹤0.01%	1008
2020 Q4	$10K	Hold	74	–	–	0.01%	738
2020 Q3	$6K	Buy	+74	New	+$4.61K	0.01%	785

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Newbridge Financial Services Group's TWST Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Twist Bioscience (TWST) in Q3 2022, closing a stake of 53 shares — an estimated $2K sold.

Newbridge Financial Services Group first reported a position in TWST in Q3 2020 and held it in 8 quarters. The position peaked at $10K in Q4 2020. 221 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

Newbridge Financial Services Group reported no remaining Twist Bioscience position as of Q3 2022 after selling out during the quarter.
Newbridge Financial Services Group sold 53 Twist Bioscience shares in Q3 2022, an estimated $2K.
Newbridge Financial Services Group first reported a position in Twist Bioscience in Q3 2020 and held it in 8 quarters.
Newbridge Financial Services Group's Twist Bioscience position peaked at $10K in Q4 2020.
221 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.